RecallDepth
Class II Terminated

PHENYLepherine HCL in 0.9% Sodium Chloride, 20 mg per 250 mL (80 mcg per mL), Rx only, SterRx, 141 Idaho Avenue, Plattsburgh, NY 12903, NDC 70324-701-01.

This recall has been terminated (originally issued January 5, 2022).

Company
Sterrx, Llc
Recall Initiated
November 12, 2021
Posted
January 5, 2022
Recall Number
D-0305-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
18,948 bags
Firm Location
Plattsburgh, NY, United States
Official Source
View on FDA website ↗

Reason for Recall

Lack of Assurance of Sterility

Distribution

U.S.A. Nationwide

Lot / Code Info

S21086/BQW 14-Dec-21 S21149/BTH 23-Jan-22 S21159/BTQ 30-Jan-22 S21265/BXI 3-Apr-22 S21305/BYU 24-Apr-22 S21311/BZA 26-Apr-22

More recalls by Sterrx, Llc

View all recalls by this company →

Other recent Class II Drug recalls